Search Results 1561-1570 of 15589 for Orange Peel tea
Patients with another malignancy in the past 3 years except: curatively treated non-melanoma skin cancer, or carcinoma in situ (either cervix or breast) ...
About this study. This randomized phase II trial studies how well standard systemic chemotherapy followed by intensified radiochemotherapy or standard ...
Veliparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as carboplatin, work in ...
This first-in-human clinical trial is a Phase 1/1b, open-label, sequential-group, dose-escalation and cohort expansion study evaluating the safety, and ...
Non-melanoma cancers of the skin; Thyroid cancer; Cervical cancer confined to the cervix or cervical intraepithelial neoplasia (CIN); Ductal carcinoma in situ ...
The only exception is localized squamous cell or basal cell carcinoma of the skin that has been definitively treated ≥10 weeks prior to screening. History ...
Other active malignancy ≤ 3 years prior to registration; EXCEPTIONS: Nonmelanotic skin cancer or carcinoma-in-situ of the cervix; NOTE: If there is a ...
History of malignancy within 5 years prior to screening with the exception of localized nonmetastatic basal cell carcinoma of the skin and in-situ carcinoma of ...
This study will find out if a new medicine called NNC6019-0001 can help reduce the risk of heart-related death and illness in participants with a condition ...
However, participants with a prior history of malignancy that has been adequately treated non-melanoma skin cancer, superficial bladder cancer are eligible.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.